inquiry@ottawainnercityhealth.ca 613-562-4500
inquiry@ottawainnercityhealth.ca 613-562-4500
Staff Portal

Buy Strattera Generic Online Visit Our Pharmacy ↓




Strattera: a Holistic Solution for Emotional Regulation and Resilience



Unlike stimulants, Strattera is a selective norepinephrine reuptake inhibitor, which means it works by increasing the levels of the neurotransmitter norepinephrine in the brain. Strattera acts on norepinephrine levels, potentially enhancing focus and reducing impulsivity, but achieving the best outcomes often hinges on complementary lifestyle adjustments. The greater levels of norepinephrine help to increase attention span, reduce hyperactivity, and improve impulse control in individuals with ADHD. Unlike traditional stimulants that carry a risk of dependency, Strattera, with its non-addictive comp, primarily aims to increase levels of norepinephrine, a key player in attention and memory processes. Some common side effects of Strattera include decreased appetite, nausea, and dizziness. It typically takes longer—several weeks, as opposed to hours—to notice the benefits, and the overall effect might be subtler. Initially, consider discussing with your doctor the possibility of prescribing a generic version if available, as generics are often more readily covered by insurance plans.



Managing Potential Side Effects



This often includes a detailed medical history, documented evidence of previous treatments tried and failed, as well as a clear medical rationale from your healthcare provider explaining why Strattera is essential for your treatment plan. Adderall contains amphetamines, making it highly addictive and prone to abuse by individuals who do not have ADHD. Do not adjust the dosage without consulting your healthcare provider. These stories highlight how Strattera has been a catalyst for individuals seeking to harness their full cognitive potential while embarking on meaningful journeys of personal growth. This could entail enlisting the aid of a patient advocate or a legal professional familiar with health insurance litigation. Managing the side effects of Strattera can be a crucial part of treatment, especially since they vary greatly among individuals. ADHD patients and experts share insightful experiences and recommendations regarding the use of various medications.



Real Stories, Real Outcomes: User Experiences Revealed



It is essential to start with a low dose initially and then gradually increase it over time. Unlike traditional stimulants that provide an immediate boost, Strattera works by increasing the levels of norepinephrine in the brain, which helps improve attention and focus gradually. It is also suitable for individuals of all ages, making it a versatile option for managing ADHD symptoms. It is essential to monitor individuals taking Strattera for any signs of these side effects and report them to a healthcare professional immediately. For individuals who have tried other medications with no success, Strattera may be a viable alternative. Strattera can help by reducing distractions, improving focus and attention, and increasing productivity. By understanding and managing these potential downsides, individuals can make informed decisions about Strattera as an ADHD treatment option.



Who Benefits from Strattera?



While Strattera is generally well-tolerated, it is important to be aware of potential side effects that may occur. Positive Changes Experienced: Since starting Strattera, I have noticed a significant improvement in my ability to focus and get tasks done. From a holistic standpoint, combining Strattera with behavioral therapy and lifestyle adjustments like regular exercise and sufficient sleep can profoundly amplify its benefits. By increasing the amount of norepinephrine in the brain, Strattera helps to improve attention, reduce impulsivity, and decrease hyperactivity. Comparing prices through online tools or apps that aggregate pharmacy prices and offer coupons can lead to substantial savings on prescription medications, ensuring patients are able to continue their treatment without financial strain. In most cases, the initial dose will be low and then gradually increased until the optimal effect is achieved. Unlike stimulants, which enhance the activity of the neurotransmitter dopamine in the brain, Strattera works by inhibiting the reuptake of norepinephrine, another neurotransmitter that regulates attention, mood, and arousal.



Understanding Adhd



These practices can act like an elixir, augmenting the drug's therapeutic effects and providing a holistic approach to ADHD management. Ultimately, the choice of medication should be based on a thorough evaluation by a healthcare professional and a consideration of the individual's unique needs, preferences, and medical history. These consultations provide an opportunity to discuss any new or ongoing symptoms, allowing your doctor to adjust your dosage or recommend additional treatments if needed. Research shows that Strattera, a non-stimulant medication for ADHD, offers unique benefits for adults. However, it is important to note that Adderall is a controlled substance and has a potential for abuse or addiction. Strattera is a non-stimulant medication that works by affecting the chemicals in the brain that contribute to impulse control and hyperactivity.The impact of Strattera can be seen in the positive changes it brings to the lives of individuals with ADHD. In fact, a study published in the Journal of Child Psychology and Psychiatry found that there was no increase in suicidality in children and adolescents with ADHD who were treated with Strattera.



The Unique Non-stimulant Advantage of Strattera



The transformative impact of Strattera on individuals grappling with ADHD is vividly illustrated through their before and after stories. First, establish a consistent routine to help your child stay organized and comfortable. However, it is important to note that Strattera may not be effective for everyone with anxiety and may cause side effects, such as nausea, dry mouth, and fatigue. All in all, with the help of Strattera, individuals can find their voice and use it with confidence, empowering them to communicate effectively in all aspects of their lives. Unlike its stimulant counterparts such as Ritalin and Adderall, Strattera works by selectively inhibiting the reuptake of norepinephrine, a neurotransmitter associated with attention and impulse control. First and foremost, it is important to consider the individual's body weight and age. Its efficacy has been demonstrated in clinical trials involving both pediatric and adult patients, showcasing its ability to effectively manage symptoms across different age groups.



Managing Side Effects and Risks of Strattera



Continuous support from trusted sources empowers individuals to make informed decisions and prioritize their well-being during treatment. Regular monitoring and communication with your healthcare provider is essential to ensure optimal results and to minimize any potential side effects. Continuous use of the medication is believed to foster a more balanced level of norepinephrine in the prefrontal cortex, a key region implicated in ADHD. Unlike stimulant medications, Strattera does not cause addiction or abuse, and therefore can be taken without fear of any such reactions. Unlike stimulant medications traditionally used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD), Strattera does not significantly affect the uptake of dopamine, the neurotransmitter often associated with the reward pathways. As a result, patients can experience improvements in daily functioning and overall well-being. Unlike stimulant drugs that target both dopamine and norepinephrine, Strattera exclusively prevents the reuptake of norepinephrine in the brain.



Long-term Effects of Strattera on Cognitive Function



Though it does not belong to the stimulant class of drugs, Strattera's elevation of norepinephrine concentration sharpens focus and contributes to the stability of alertness. Strattera has shown promising results in enhancing focus and attention in adults with ADHD. Its mechanism of action also aids in reducing aggression and oppositional behavior, allowing individuals to better manage their emotions and adapt socially. In reality, Strattera, whose generic name is atomoxetine, is a non-stimulant treatment. This Comp medication has been shown to offer several advantages over stimulants, including a lower potential for abuse and a more gradual onset of effects. These neurological side effects underscore the importance of close monitoring by healthcare professionals during treatment with Strattera, to ensure patient safety and the appropriate management of any adverse effects that may arise. Patients are advised to discuss any concerns about the availability and cost of Strattera with their healthcare provider.



Understanding Strattera: the Non-stimulant Approach



By understanding these prerequisites, you can coordinate with your healthcare provider to prepare any necessary documentation or satisfy insurer conditions, increasing the likelihood that your treatment will be covered without unnecessary delays. John, a 35-year-old graphic designer, shared that his script for Strattera made a "night and day" difference in his ability to manage deadlines and multitask. Attention Deficit Hyperactivity Disorder (ADHD) presents a myriad of challenges that extend beyond the typical energy and attention struggles. Consistent communication with healthcare professionals is essential when taking Strattera. It is important to consult with a healthcare provider before starting Strattera, and to report any side effects immediately. Taking Strattera can be a life-changing decision for individuals with ADHD, as it can help them manage their symptoms and function effectively in their daily lives. The impact of ADHD on daily life can be significant, affecting academic and work performance, social relationships, and overall quality of life.



Treating Adhd with Traditional Medications



Parents and healthcare providers may prefer.Strattera for treating children whose symptoms may not have responded well to stimulants, or who may be at risk for stimulant abuse. The effectiveness of Strattera compared to traditional stimulants in treating ADHD varies among individuals. Strattera (atomoxetine), a non-stimulant medication, has been a turning point for many, aiding in the sharpening of focus and the improvement of executive functions. Factors such as age, weight, and how the body metabolizes the medication play crucial roles. In rare cases, Strattera can cause severe liver damage, and patients should seek medical attention right away if they experience symptoms such as dark urine, yellowing of the skin or eyes, or persistent abdominal pain. Users have reported improvements in their ability to plan and execute tasks, leading to enhanced productivity and reduced stress. While some users experience nausea or dizziness, these usually subside as the body adjusts.

Dr. Simon Hatcher

Medical Director of Psychiatry

Dr. Simon Hatcher is a Psychiatrist at the Ottawa Hospital and Medical Director of Psychiatry at Ottawa Inner City Health, a Scientist at the Ottawa Hospital Research Institute, and a Full Professor and Chair of the Department of Psychiatry at the University of Ottawa. He has worked as a psychiatrist in clinical, research and leadership roles in non-mental health settings all his professional career starting in Leeds, UK followed by 20 years in Auckland, New Zealand before moving to Canada in 2012. Dr. Hatcher is not good at many things but one thing he does try to do well is to give a voice and meaning to people who are suffering from mental disorders. This is integrated into clinical care, teaching, and research through the Hatching Ideas Lab. Away from his professional work, he keeps bees and rides motorbikes, but not both at the same time.

Dr. Rakesh Patel

Medical Director

Dr Rakesh V. Patel is an Associate Prof. of Medicine at U Ottawa. Currently, he is the Medical Director of Ottawa Inner City Health and has been working there since 2018. He completed his General Internal Medicine (GIM) residency in Ottawa (2001), GIM Fellowship [2003, McMaster] and his adult critical care medicine residency training at U of Ottawa (2004). He was the Program Director for the UOttawa adult critical care medicine residency program and has been practicing Adult Critical Care and Internal Medicine, at The Ottawa Hospital (TOH), since 2004. He has chaired the Pharmacy and Therapeutics Committee for TOH-UOHI since 2007. He is a member of the Committee to Evaluate Drugs, Ministry of Health, Ontario. His research interests include; clinical pharmacology/therapeutics, and medical education. He received the “Clinical Teacher of the Year” award from GIM residents in 2007 and the “Outstanding Physician” award from the Dept. of Medicine in 2018. One day, he hopes to shoot par at the Old Course at St. Andrews.

Kim Van Herk

Mental Health Nurse Coordinator Team Lead

As Team Lead for the Mental Health Nurse Coordinators at OICH, Kim combines extensive expertise, heartfelt leadership, and a deep commitment to compassionate care. She earned her Bachelor of Nursing from McMaster University and her Master’s degree from Ottawa University, where her research focused on improving access to care for pregnant and parenting Aboriginal women in urban settings. As another longtime OICH nurse, Kim is known for her empathetic leadership style and her ability to foster a culture of courage, inclusivity, and trust. With a wealth of experience in mental health care for vulnerable populations, she ensures that every individual feels seen, supported, and valued. Outside of her professional role, Kim finds joy in spending time with her kids, immersing herself in nature, and reading.

Christina Masters

Nurse Coordinator Team Lead

As Team Lead for the Nurse Coordinators at Ottawa Inner City Health, Christina Masters brings a sharp analytical mind, deep compassion, and extensive nursing expertise to her role. She earned her Nursing degree from the University of Ottawa and began her career in the emergency room, holding an emergency nursing certification from the Canadian Nurses Association. Christina is a dedicated harm reduction leader, passionate about education and development. Christina never shies from jumping into a complex, challenging medical situation. Her thoughtful approach ensures every client feels seen, valued, and supported. Within her team, Christina is the steadying force—the glue that holds everyone together. Outside of work, Christina enjoys spending time with her kids, caring for her chickens, cross-stitching intricate patterns, and baking delicious treats.

Louise Beaudoin

Nursing Manager

Louise Beaudoin has been a part of Ottawa Inner City Health since its early days when OICH was a pilot project. She earned her Bachelor of Nursing from the Université du Québec and brings decades of dedication and expertise to her role as RPN Manager. Passionate about working in the grey areas of harm reduction, Louise thrives on finding flexible solutions that meet the community’s unique needs. Outside of work, Louise is all about physical activity and sports! She keeps active and energized through skiing, cycling, and yoga.

Anne Marie Hopkins

Director of Operations

With a background in Social Work and a Master’s in Business Administration, Anne Marie combines compassionate, people-focused care with strategic leadership in her role as Director of Operations. Anne Marie began her journey with Ottawa Inner City Health in 2008 as a volunteer and has since held multiple roles within the organization. Anne Marie is passionate about building community and loves working in the mental health and substance use field, drawn to the complexity, nuance, and humanity of the harm reduction world. Anne Marie’s happiest moment in her career was being part of the team that launched OICH’s Supervised Consumption Site in 2017. Outside of her professional life, Anne Marie is passionate about dogs, reading her Kindle, being outdoors, and quilting.

Joanne Rousseau

Director of Human Resources

Joanne holds a Bachelor of Arts in Sociology from the University of Windsor and a Human Resources diploma. She is a Certified Human Resources Leader (CHRL). While she’s newer to the OICH team, Joanne brings extensive experience in HR leadership and managing large teams. After years in the corporate world, Joanne sought a role with purpose and heart where her work could make a meaningful impact on the community. In her spare time, Joanne enjoys reading Jane Austen novels, watching Doctor Who, puzzling, and musicals. If you’ve visited the OICH office, you’ve likely been greeted by Lily, Joanne’s friendly office dog.

Rob Boyd

Chief Executive Officer

Rob has worked at the intersection of homelessness, mental health and substance use health in Ottawa for the past 35 years, including over 20 years in senior leadership positions. He has extensive experience in developing programs and services centred on clients’ needs and responsive to the changing environment in which they live. Rob is a champion for the inclusion of people with lived experience in all aspects of the work being done, from systems advocacy to service delivery. Rob lives in the country and likes working around his property and spending time outdoors. He is known as the office dog whisperer, likely due to his calm nature and relaxed energy.